AI Science Tracker
EN

The First Affiliated Hospital of Chongqing Medical University

4 discoveries from 2025

Discoveries

Machine Learning Strategies for Preoperative PJI Diagnosis: Integrative Analysis of Serum and Synovial Fluid Markers.

Source check: Source checked. Not independent scientific confirmation.

Finding: Using serum and synovial-fluid markers from 376 revision-surgery patients, the study trained eight machine-learning models for preoperative periprosthetic-joint-infection diagnosis. XGBoost achieved AUC 0.998 in the test set and was compared with MSIS 2013 and ICM 2018 criteria in an external cohort. The study reports diagnostic performance, not improved patient outcomes. The result is reported in Journal of Inflammation Research. The study does not establish generalization beyond its reported setting or prospective real-world benefit.

Technology: LASSO selected serum and synovial-fluid markers for eight machine-learning models; XGBoost was compared with established PJI criteria in an external revision-surgery cohort.

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
LASSO selected serum and synovial-fluid markers for eight machine-learning models; XGBoost was compared with established PJI criteria in an external revision-surgery cohort.
Test and result
The primary full text supports the case-specific result: The preoperative joint-infection model is tested against established diagnostic criteria and an external cohort of revision-surgery patients.
Limitation / still unknown
Independent replication and prospective real-world benefit are not established in the reviewed study.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12326324/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

An Integrated Machine Learning Framework for Developing and Validating a Diagnostic Model of Hub Genes Related to Lipid Metabolism in Chronic Rhinosinusitis.

Source check: Source checked. Not independent scientific confirmation.

Finding: The primary full text supports the case-specific result: Integrated analysis identified lipid-metabolism genes and validated a diagnostic model for chronic rhinosinusitis. The result is reported in Journal of Inflammation Research. The study does not establish generalization beyond its reported setting or prospective real-world benefit.

Technology: A combined random-forest and stepwise generalized-linear-model diagnostic classifier selected six genes from chronic-rhinosinusitis expression data; qRT-PCR and immunofluorescence checked expression of three genes.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
A combined random-forest and stepwise generalized-linear-model diagnostic classifier selected six genes from chronic-rhinosinusitis expression data; qRT-PCR and immunofluorescence checked expression of three genes.
Test and result
The study identified 41 hub genes and developed a combined random-forest/stepwise-GLM six-gene diagnostic model with AUC 0.848. qRT-PCR and immunofluorescence confirmed higher RAB35, GLE1 and OSMR expression in chronic-rhinosinusitis samples than controls. Findings are cohort-specific and do not establish clinical benefit.
Limitation / still unknown
Independent replication and prospective real-world benefit are not established in the reviewed study.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12318519/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Development and validation of inpatient mortality prediction models for patients with hyperglycemic crisis using machine learning approaches.

Source check: Source checked. Not independent scientific confirmation.

Finding: The primary full text supports the specific AI-enabled finding: Machine-learning models predicted inpatient mortality among hyperglycemic-crisis patients using clinical records.

Technology: Machine-learning mortality-prediction models for hyperglycemic crisis

Publication: Peer-reviewed paper · Test context: prospective or independent check. Catalog categories, not an evidence grade.

AI contribution
Uses clinical records to predict inpatient mortality among patients with hyperglycemic crisis.
Test and result
The paper reports the relevant cohort/image/field dataset, comparator or reference, and validation/test evaluation; the judgment does not imply prospective clinical benefit.
Limitation / still unknown
The reported evaluation does not establish prospective benefit or performance beyond the studied setting.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11948940/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 4/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Risk factor assessment of prediabetes and diabetes based on epidemic characteristics in new urban areas: a retrospective and a machine learning study

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: In a retrospective cohort of 47,608 adults from Chongqing medical examinations, the authors combine epidemiologic analysis with ML risk estimation; diabetes prevalence was 5.0±0.6%, prediabetes 5.3±2.0%, and an ML classifier achieved precision 0.76, recall 0.86, F1 0.81. This is a specific local epidemiology/risk result, with single-region retrospective limits.

Technology: Original Methods examined; learned operation linked to the stated result as summarized in reason.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Original Methods examined; learned operation linked to the stated result as summarized in reason.
Limitation / still unknown
The result is limited to the reported dataset, experimental setting and validation in this study; broader generalization and real-world benefit are not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.nature.com/articles/s41598-025-88073-6 · https://pubmed.ncbi.nlm.nih.gov/39885216/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.